Related Experiment Video
Updated: May 20, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Novel role of PKR in inflammasome activation and HMGB1 release
Ben Lu1, Takahisa Nakamura, Karen Inouye
1Laboratory of Biomedical Science, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, USA. blu@nshs.edu
Abstract:
The inflammasome regulates the release of caspase activation-dependent cytokines, including interleukin (IL)-1β, IL-18 and high-mobility group box 1 (HMGB1). By studying HMGB1 release mechanisms, here we identify a role for double-stranded RNA-dependent protein kinase (PKR, also known as EIF2AK2) in inflammasome activation. Exposure of macrophages to inflammasome agonists induced PKR autophosphorylation. PKR inactivation by genetic deletion or pharmacological inhibition severely impaired inflammasome activation in response to double-stranded RNA, ATP, monosodium urate, adjuvant aluminium, rotenone, live Escherichia coli, anthrax lethal toxin, DNA transfection and Salmonella typhimurium infection. PKR deficiency significantly inhibited the secretion of IL-1β, IL-18 and HMGB1 in E. coli-induced peritonitis. PKR physically interacts with several inflammasome components, including NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3), NLRP1, NLR family CARD domain-containing protein 4 (NLRC4), absent in melanoma 2 (AIM2), and broadly regulates inflammasome activation. PKR autophosphorylation in a cell-free system with recombinant NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC, also known as PYCARD) and pro-caspase-1 reconstitutes inflammasome activity. These results show a crucial role for PKR in inflammasome activation, and indicate that it should be possible to pharmacologically target this molecule to treat inflammation.
Insights
Double-stranded RNA-dependent protein kinase (PKR) is crucial for inflammasome activation. Inhibiting PKR can potentially treat inflammatory diseases by blocking cytokine release.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Signaling
Background:
- The inflammasome complex orchestrates the release of key inflammatory cytokines, including IL-1β, IL-18, and HMGB1.
- Understanding the mechanisms regulating inflammasome activation is critical for developing targeted anti-inflammatory therapies.
Purpose of the Study:
- To investigate the role of double-stranded RNA-dependent protein kinase (PKR, also known as EIF2AK2) in inflammasome activation.
- To elucidate the molecular mechanisms by which PKR influences inflammasome signaling.
Main Methods:
- Macrophage stimulation with various inflammasome agonists.
- Genetic deletion and pharmacological inhibition of PKR.
- Assessment of cytokine release (IL-1β, IL-18, HMGB1).
- Co-immunoprecipitation assays to study protein interactions.
- In vitro reconstitution of inflammasome activity using recombinant proteins.
Main Results:
- PKR autophosphorylation was induced upon exposure to inflammasome agonists.
- PKR deficiency or inhibition significantly impaired inflammasome activation across diverse stimuli, including bacterial and viral components, ATP, and crystalline substances.
- PKR physically interacts with multiple inflammasome components (NLRP3, NLRP1, NLRC4, AIM2).
- Reconstitution of inflammasome activity was achieved using PKR, NLRP3, ASC, and pro-caspase-1 in a cell-free system.
Conclusions:
- PKR plays a pivotal and broad role in regulating inflammasome activation.
- PKR represents a potential therapeutic target for managing inflammatory conditions.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response
Gastritis II: Pathophysiology
Caspases
The JAK-STAT Signaling Pathway
The Unfolded Protein Response

